• Board
• Departments
• Administration
• Faculty of Medicine

| Home > Departments > Center for Diagnostic > Department of Clinical Chemistry/Central Laboratories > Publications

Publications

Prof. Dr. H. Schlüter

2010

• Niklew ML, Hochkirch U, Melikyan A, Moritz T, Kurzawski S, Schlüter H, Ebner I, Linscheid MW: Phosphopeptide screening using nanocrystalline titanium dioxide films as affinity matrix-assisted laser desorption ionization targets in mass spectrometry. Anal Chem 2010; 82:1047-1053.

2009

• Schulz-Trieglaff O, Machtejevas E, Reinert K, Schlüter H, Thiemann J, Unger K: Statistical quality assessment and outlier detection for liquid chromatography-mass spectrometry experiments. BioData Min 2009;2:4.
• Schlüter H, Apweiler R, Holzhütter HG, Jungblut PR: Finding one's way in proteomics: a protein species nomenclature. Chem Cent J 2009;3:11.
• Ahrends R, Lichtner B, Bertsch A, Kohlbacher O, Hildebrand D, Trusch M, Schlüter H: Application of displacement chromatography for the proteome analysis of a human plasma protein fraction. J Chromatogr A 2009.
• Trusch M, Bohlick A, Hildebrand D, Lichtner B, Bertsch A, Kohlbacher O, Bachmann S, Schlüter H: Application of displacement chromatography for the analysis of a lipid raft proteome. J Chromatogr B Analyt Technol Biomed Life Sci 2009.
  

2008

• Welker P, Boehlick A, Mutig K, Salanova M, Kahl T, Schlüter H, Blottner D, Ponce-Coria J, Gamba G, Bachmann S. Renal Na-K-Cl Cotransporter
  Activity and Vasopressin-Induced Trafficking Are Lipid Raft-Dependent. Am J Physiol Renal Physiol. 2008; 295(3): F789-802.
• Schlüter H, Hildebrand D, Gallin C, Schulz A, Thiemann J, Trusch M. Mass spectrometry for monitoring protease reactions. Anal Bioanal Chem. 2008; 392(5): 783-792.
• Jungblut PR, Holzhutter HG, Apweiler R, Schlüter H. The speciation of the proteome. Chem Cent J. 2008; 2: 16.
• Eravci M, Fuxius S, Broedel O, Weist S, Krause E, Stephanowitz H, Schlüter H, Eravci S, Baumgartner A. The whereabouts of transmembrane proteins from rat brain synaptosomes during two-dimensional gel electrophoresis. Proteomics. 2008; 8(9): 1762-1770.
• Schlüter H, Trusch M, Jungblut PR. Protein Species - the Future Challenge for Enzymology. In: Experimental Standard Conditions of Enzyme Characterizations. Eds. Hicks MG, Kettner C. Berlin: Logos; 2008: Pages 123-136.
• Bobbert P, Schlüter H, Schultheiss HP, Reusch HP. Diadenosine polyphosphates Ap3A and Ap4A, but not Ap5A or Ap6A, induce proliferation of vascular smooth muscle cells. Biochem Pharmacol. 2008; 75(10): 1966-1973.

2007

• Schlüter H, Rykl J, Thiemann J, Kurzawski S, Gobom J, Tepel M, Zidek W, Linscheid M. Mass spectrometry-assisted protease substrate screening. Anal Chem. 2007; 79: 1251-1255.
• Schlüter H. Investigation of Proteases - Suggestions. In: Experimental Standard Conditions of Enzyme Characterizations. Eds. Hicks MG, Kettner C. Berlin: Logos; 2007: Pages 203-211.
• Jankowski V, Vanholder R, van der Giet M, Tolle M, Karadogan S, Gobom J, Furkert J, Oksche A, Krause E, Tran TN, Tepel M, Schuchardt M, Schlüter H, Wiedon A, Beyermann M, Bader M, Todiras M, Zidek W, Jankowski J. Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol. 2007; 27(2): 297-302.
• Eravci M, Fuxius S, Broedel O, Weist S, Eravci S, Mansmann U, Schlüter H, Tiemann J, Baumgartner A. Improved comparative proteome analysis based on two-dimensional gel electrophoresis. Proteomics. 2007; 7(4): 513-523.

2006

• Rykl J, Thiemann J, Kurzawski S, Pohl T, Gobom J, Zidek W, Schlüter H. Renal cathepsin G and angiotensin II generation. J Hypertens. 2006; 24(9): 1797-1807.
• Luo J, Jankowski V, Henning L, Schlüter H, Zidek W, Jankowski J. Endogenous coenzyme A glutathione disulfide in human myocardial tissue. J Endocrinol Invest. 2006; 29(8): 688-693.

2005

• Jankowski V, Vanholder R, van der Giet M, Henning L, Tolle M, Schonfelder G, Krakow A, Karadogan S, Gustavsson N, Gobom J, Webb J, Lehrach H, Giebing G, Schlüter H, Hilgers KF, Zidek W, Jankowski J. Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension. 2005; 46(3): 591-597.
• Jankowski V, Vanholder R, Henning L, Karadogan S, Zidek W, Schlüter H, Jankowski J. Isolation and quantification of dinucleoside polyphosphates by using monolithic reversed phase chromatography columns. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 819(1): 131-139.
• Jankowski V, Tolle M, Vanholder R, Schonfelder G, van der Giet M, Henning L, Schlüter H, Paul M, Zidek W, Jankowski J. Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nature Med. 2005; 11(2): 223-227.

2004

• Yoon MS, Jankowski V, Montag S, Zidek W, Henning L, Schlüter H, Tepel M, Jankowski J. Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus. Biochem Biophys Res Commun. 2004; 323(2): 377-381.
• Thiemann J, Jankowski J, Rykl J, Kurzawski S, Pohl T, Wittmann-Liebold B, Schlüter H. Principle and applications of the protein-purification-parameter screening system. J Chromatogr A. 2004; 1043(1): 73-80.
• Schlüter H, Jankowski J, Thiemann J, Rykl J, Kurzawski S, Runge D. Determination of enzyme activities by mass spectrometry. In: Experimental Standard Conditions of Enzyme Characterizations. Eds. Hicks MG, Kettner C. Berlin: Logos Verlag; 2004: Pages.
• Luo J, Jankowski V, Gungar N, Neumann J, Schmitz W, Zidek W, Schlüter H, Jankowski J. Endogenous diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate in human myocardial tissue. Hypertension. 2004; 43(5): 1055-1059.
• Jankowski J, Henning L, Schlüter H. Analysis of the releasable nucleotides of platelets. Methods Mol Biol. 2004; 272: 97-108.

2003

• Westhoff T, Jankowski J, Schmidt S, Luo J, Giebing G, Schlüter H, Tepel M, Zidek W, van der Giet M. Identification and characterization of adenosine 5'-tetraphosphate in human myocardial tissue. J Biol Chem. 2003; 278(20): 17735-17740.
• Schlüter H, Jankowski J, Rykl J, Thiemann J, Belgardt S, Zidek W, Wittmann B, Pohl T. Detection of protease activities with the mass-spectrometry-assisted enzyme-screening (MES) system. Anal Bioanal Chem. 2003; 377(7-8): 1102-1107.
• Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schlüter H, Zidek W, Tepel M. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003; 112(2): 256-264.
  Jankowski J, Schlüter H, Henning L, van der Giet M, Jankowski V, Zidek W, Tepel M. The AN69 hemofiltration membrane has a decreasing effect on the intracellular diadenosine pentaphosphate concentration of platelets. Kidney Blood Press Res. 2003; 26(1): 50-54.
• Jankowski J, Jankowski V, Seibt B, Henning L, Zidek W, Schlüter H. Identification of dinucleoside polyphosphates in adrenal glands. Biochem Biophys Res Commun. 2003; 304(2): 365-370.
• Jankowski J, Jankowski V, Laufer U, van der Giet M, Henning L, Tepel M, Zidek W, Schlüter H. Identification and quantification of diadenosine polyphosphate concentrations in human plasma. Arterioscler Thromb Vasc Biol. 2003; 23(7): 1231-1238.
• Jankowski J, Grosse-Huttmann P, Zidek W, Schlüter H. Identification of dinucleoside polyphosphates by matrix-assisted laser desorption/ionisation post-source decay mass spectrometry. Rapid Commun Mass Spectrom. 2003; 17(11): 1189-1194.

2002

• van der Giet M, Schmidt S, Tolle M, Jankowski J, Schlüter H, Zidek W, Tepel M. Effects of dinucleoside polyphosphates on regulation of coronary vascular tone. Eur J Pharmacol. 2002; 448(2-3): 207-213.

2001

• van der Giet M, Westhoff T, Cinkilic O, Jankowski J, Schlüter H, Zidek W, Tepel M. The critical role of adenosine and guanosine in the affinity of dinucleoside polyphosphates to P(2X)-receptors in the isolated perfused rat kidney. Br J Pharmacol. 2001; 132(2): 467-474.
• van der Giet M, Schmid A, Jankowski J, Schlüter H, Zidek W, Tepel M. CoenzymeA glutathione disulfide is a potent modulator of angiotensin II-induced vasoconstriction. Am J Hypertens. 2001; 14(2): 164-168.
• Ralevic V, Jankowski J, Schlüter H. Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed. Br J Pharmacol. 2001; 134(5): 1073-1083.
• Jankowski J, Yoon MS, Stephan N, Zidek W, Schlüter H. Vasoactive diadenosine polyphosphates in human placenta: possible candidates in the pathophysiology of pre-eclampsia? J Hypertens. 2001; 19(3 Pt 2): 567-573.
• Jankowski J, Tepel M, Stephan N, van der Giet M, Breden V, Zidek W, Schlüter H. Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure. Kidney Int Suppl. 2001; 78: S84-88.
• Jankowski J, Stephan N, Knobloch M, Fischer S, Schmaltz D, Zidek W, Schlüter H. Mass-spectrometry-linked screening of protein fractions for enzymatic activities--a tool for functional genomics. Anal Biochem. 2001; 290(2): 324-329.
• Jankowski J, Hagemann J, Yoon MS, van der Giet M, Stephan N, Zidek W, Schlüter H, Tepel M. Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int. 2001; 59(3): 1134-1141.
• Jankowski J, Hagemann J, Tepel M, van Der Giet M, Stephan N, Henning L, Gouni-Berthold I, Sachinidis A, Zidek W, Schlüter H. Dinucleotides as growth-promoting extracellular mediators. Presence of dinucleoside diphosphates Ap2A, Ap2G, and Gp2G in releasable granules of platelets. J Biol Chem. 2001; 276(12): 8904-8909.
• Cinkilic O, King BF, van der Giet M, Schlüter H, Zidek W, Burnstock G. Selective agonism of group I P2X receptors by dinucleotides dependent on a single adenine moiety. J Pharmacol Exp Ther. 2001; 299(1): 131-136.

2000

• Schlüter H, Jankowski J. Displacement Chromatography. Amsterdam: Elsevier Science; 2000: Pages.
• Schlüter H. Reversed-Phase Chromatography. Amsterdam: Elsevier Science; 2000: Pages.
• Lewis CJ, Gitterman DP, Schlüter H, Evans RJ. Effects of diadenosine polyphosphates (Ap(n)As) and adenosine polyphospho guanosines (Ap(n)Gs) on rat mesenteric artery P2X receptor ion channels. Br J Pharmacol. 2000; 129(1): 124-130.
• Jankowski J, Schroter A, Tepel M, van der Giet M, Stephan N, Luo J, Zidek W, Schlüter H. Isolation and characterization of coenzyme A glutathione disulfide as a parathyroid-derived vasoconstrictive factor. Circulation. 2000; 102(20): 2548-2552.

1999

• Verspohl EJ, Johannwille B, Kaiserling-Buddemeier I, Schlüter H, Hagemann J. Diadenosine polyphosphates in cultured vascular smooth-muscle cells and endothelium cells--their interaction with specific receptors and their degradation. J Pharm Pharmacol. 1999; 51(10): 1175-1181.
• van der Giet M, Cinkilic O, Jankowski J, Tepel M, Zidek W, Schlüter H. Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney. Br J Pharmacol. 1999; 127(6): 1463-1469.
• Vahlensieck U, Boknik P, Gombosova I, Huke S, Knapp J, Linck B, Luss H, Muller HL, Neumann J, Deng MC, Scheld HH, Jankowski H, Schlüter H, Zidek W, Zimmermann N, Schmitz W. Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations. J Pharmacol Exp Ther. 1999; 288(2): 805-813.
• Tepel M, Pytlik M, van der Giet M, Schlüter H, Jankowski J, Zidek W. Effect of dexamethasone on the lymphocytic Na+/H+ antiporter activity. J Hypertens. 1999; 17(11): 1553-1556.
• Neumann J, Meissner A, Boknik P, Gombosova I, Knapp J, Luss H, Muller FU, Schlüter H, Zidek W, Rolf N, Van Aken H, Vahlensieck U, Schmitz W. Inotropic effects of diadenosine tetraphosphate in isolated canine cardiac preparations. J Cardiovasc Pharmacol. 1999; 33(1): 151-156.
• Luo J, Jankowski J, Tepel M, von Der Giet M, Zidek W, Schlüter H. Identification of diadenosine hexaphosphate in human erythrocytes. Hypertension. 1999; 34(4 Pt 2): 872-875.
• Luo J, Jankowski J, Knobloch M, Van der Giet M, Gardanis K, Russ T, Vahlensieck U, Neumann J, Schmitz W, Tepel M, Deng MC, Zidek W, Schlüter H. Identification and characterization of diadenosine 5',5"'-P1,P2 -diphosphate and diadenosine 5',5"'-P1,P3-triphosphate in human myocardial tissue. Faseb J. 1999; 13(6): 695-705.
• Knapp J, Boknik P, Linck B, Laer S, Muller FU, Neumann J, Vahlensieck U, Schlüter H, Zidek W, Schmitz W. Inositol-1,4,5-trisphosphate increase by diadenosine tetraphosphate in preparations from failing human myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1999; 360(3): 354-357.
  Jankowski J, Tepel M, van der Giet M, Tente IM, Henning L, Junker R, Zidek W, Schlüter H. Identification and characterization of P(1), P(7)-Di(adenosine-5')-heptaphosphate from human platelets. J Biol Chem. 1999; 274(34): 23926-23931.
• Jankowski J, Potthoff W, van der Giet M, Tepel M, Zidek W, Schlüter H. High-performance liquid chromatographic assay of the diadenosine polyphosphates in human platelets. Anal Biochem. 1999; 269(1): 72-78.

1998

• van der Giet M, Jankowski J, Schlüter H, Zidek W, Tepel M. Mediation of the vasoactive properties of diadenosine tetraphosphate via various purinoceptors. J Hypertens. 1998; 16(12 Pt 2): 1939-1943.
• Schlüter H, Grobeta I, Bachmann J, Kaufmann R, van der Giet M, Tepel M, Nofer JR, Assmann G, Karas M, Jankowski J, Zidek W. Adenosine(5') oligophospho-(5') guanosines and guanosine(5') oligophospho-(5') guanosines in human platelets. J Clin Invest. 1998; 101(3): 682-688.
• Jankowski J, Potthoff W, Zidek W, Schlüter H. Purification of chemically synthesised dinucleoside(5',5') polyphosphates by displacement chromatography. J Chromatogr B Biomed Sci Appl. 1998; 719(1-2): 63-70.
• Jankowski J, Nofer JR, Tepel M, Griewel B, Schlüter H, Assmann G, Zidek W. Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy. Clin Sci (Lond). 1998; 95(4): 489-495.
• Jankowski J, Luftmann H, Tepel M, Leibfritz D, Zidek W, Schlüter H. Characterization of dimethylguanosine, phenylethylamine, and phenylacetic acid as inhibitors of Ca2+ ATPase in end-stage renal failure. J Am Soc Nephrol. 1998; 9(7): 1249-1257.
• Brandts B, Brandts A, Wellner-Kienitz MC, Zidek W, Schlüter H, Pott L. Non-receptor-mediated activation of IK(ATP) and inhibition of IK(ACh) by diadenosine polyphosphates in guinea-pig atrial myocytes. J Physiol. 1998; 512 ( Pt 2): 407-420.

1997

• van der Giet M, Khattab M, Borgel J, Schlüter H, Zidek W. Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol. 1997; 120(8): 1453-1460.
• Tepel M, Jankowski J, Schlüter H, Bachmann J, van der Giet M, Ruess C, Terliesner J, Zidek W. Diadenosine polyphosphates' action on calcium and vessel contraction. Am J Hypertens. 1997; 10(12 Pt 1): 1404-1410.
• Schlüter H, Mentrup D, Gross I, Meyer HE, Spengler B, Kaufmann R, Zidek W. Identification of endogenous Des-Arg9-[Hyp3]-bradykinin in human plasma with post-source-decay matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem. 1997; 246(1): 15-19.
• Jankowski J, Schlüter H, Tepel M, Spieker C, Zidek W. Effect of diadenosine polyphosphates on Ca2+ ATPase activity. J Mol Med. 1997; 75(9): 674-677.

1996

• Vahlensieck U, Boknik P, Knapp J, Linck B, Muller FU, Neumann J, Herzig S, Schlüter H, Zidek W, Deng MC, Scheld HH, Schmitz W. Negative chronotropic and inotropic effects exerted by diadenosine hexaphosphate (AP6A) via A1-adenosine receptors. Br J Pharmacol. 1996; 119(5): 835-844.
• Tepel M, Lowe S, Nofer JR, Assmann G, Schlüter H, Zidek W. Diadenosine polyphosphates regulate cytosolic calcium in human fibroblast cells by interaction with P2x purinoceptors coupled to phospholipase C. Biochim Biophys Acta. 1996; 1312(2): 145-150.
• Tepel M, Klaus T, Laukemper S, Schlüter H, Zidek W. Increased lymphocytic Na+/H+ exchange activity after hemodialysis: evidence for an endogenous inhibitor of Na+/H+ exchange in patients with end-stage renal failure. Life Sci. 1996; 59(18): 1545-1552.
• Tepel M, Heidenreich S, Schlüter H, Beinlich A, Nofer JR, Walter M, Assmann G, Zidek W. Diadenosine polyphosphates induce transplasma membrane calcium influx in cultured glomerular mesangial cells. Eur J Clin Invest. 1996; 26(12): 1077-1084.
• Tepel M, Bachmann J, Schlüter H, Zidek W. Diadenosine polyphosphates increase cytosolic calcium and attenuate angiotensin-II-induced changes of calcium in vascular smooth muscle cells. J Vasc Res. 1996; 33(2): 132-138.
• Schlüter H, Tepel M, Zidek W. Vascular actions of diadenosine phosphates. J Auton Pharmacol. 1996; 16(6): 357-362.
• Hohage H, Reinhardt C, Borucki U, Enck G, Schlüter H, Schlatter E, Zidek W. Effects of diadenosine polyphosphates on renal function and blood pressure in anesthetized Wistar rats. J Am Soc Nephrol. 1996; 7(8): 1216-1222.

1995

• Tepel M, Bachmann J, Schlüter H, Zidek W. Diadenosine polyphosphate-induced increase in cytosolic free calcium in vascular smooth muscle cells. J Hypertens. 1995; 13(12 Pt 2): 1686-1688.
• Schlüter H, Meissner M, van der Giet M, Tepel M, Bachmann J, Gross I, Nordhoff E, Karas M, Spieker C, Witzel H, et al. Coenzyme A glutathione disulfide. A potent vasoconstrictor derived from the adrenal gland. Circ Res. 1995; 76(4): 675-680.
• Kleta R, Hirsch J, Heidenreich S, Schlüter H, Zidek W, Schlatter E. Effects of diadenosine polyphosphates, ATP and angiotensin II on membrane voltage and membrane conductances of rat mesangial cells. Pflugers Arch. 1995; 430(5): 713-720.
• Heidenreich S, Tepel M, Schlüter H, Harrach B, Zidek W. Regulation of rat mesangial cell growth by diadenosine phosphates. J Clin Invest. 1995; 95(6): 2862-2867.

1994

• Spieker C, Fischer S, Zierden E, Schlüter H, Tepel M, Zidek W. Cellular Ca2+ ATPase activity in diabetes mellitus. Horm Metab Res. 1994; 26(11): 544-547.
• Schlüter H, Offers E, Bruggemann G, van der Giet M, Tepel M, Nordhoff E, Karas M, Spieker C, Witzel H, Zidek W. Diadenosine phosphates and the physiological control of blood pressure. Nature. 1994; 367(6459): 186-188.

1993

• Spieker C, Pan N, Schlüter H, Zidek W. Ca2+ ATPase activity in essential and renal hypertension. Clin Exp Hypertens. 1993; 15(1): 143-152.
• Schlüter H, Zidek W. Application of non-size-related separation effects to the purification of biologically active substances with a size-exclusion gel. J Chromatogr A. 1993; 639: 17-22.
• Schlüter H, Kluth B, Borjesson-Stoll R, Nordhoff E, Zidek W. Partial purification and characterization of a circulating hypertensive factor in spontaneously hypertensive rats. Eur J Biochem. 1993; 218(1): 67-73.

1992

• Schlüter H, Quante C, Buchholz B, Dietl KH, Spieker C, Karas M, Zidek W. A vasopressor factor partially purified from human parathyroid glands. Biochem Biophys Res Commun. 1992; 188(1): 323-329.
• Schlüter H, Krivoy N, Hurster A, Ingendoh A, Karas M, Zidek W. Application of cross-flow filtration to the purification of biologically active peptides in human plasma after incubation with a protease-rich extract. J Chromatogr. 1992; 625(1): 3-11.
• Krivoy N, Schlüter H, Karas M, Zidek W. Generation of angiotensin II from human plasma by tissue kallikrein. Clin Sci (Lond). 1992; 83(4): 477-482.
• Agha A, Schlüter H, Konig S, Biel K, Tepel M, Zidek W. A novel platelet-derived renal vasoconstrictor agent in normotensives and essential hypertensives. J Vasc Res. 1992; 29(3): 281-289.

1991

• Bachmann J, Schlüter H, Storkebaum W, Witzel H, Wessels F, Zidek W. Effect of plasma from patients with essential hypertension on vascular resistance in the isolated perfused rat kidney. Clin Sci (Lond). 1991; 80(1): 17-23.

1990

• Zidek W, Bachmann J, Schlüter H, Witzel H, Storkebaum W, Sachinidis A. Effect of plasma from essential hypertensives on tension of aortic strips. Clin Exp Hypertens A. 1990; 12(3): 365-381.
• Bachmann J, Schlüter H, Storkebaum W, Witzel H, Zidek W. Effect of plasma from essential hypertensives on vascular tone of aortic strips, isolated perfused mesentery and isolated perfused kidney. Life Sci. 1990; 47(15): 1365-1374.
  

PD Dr. Friedrich Buck

2008

• Duning, K., Buck, F., Barnekow, A. and Kremerskothen J. (2008)  SYNCRIP, a component of dendritically localized  mRNPs, binds to the translation regulator BC200 RNA.
  Journal of Neurochemistry. 105, 351-359
• Georgieva, D., Risch, M., Kardas, A., Buck, F., von Bergen. M. and Betzel, C. (2008) Comparative analysis of the venom proteomes of Vipera  ammodytes ammodytes and Vipera ammodytes meridionalis.  Journal of Proteome Research.  7, 866-886
• Brandt, N., Franke, K., Johannes, S., Buck, F., Harder, S., Hassel, B., Nitsch, R. and Schumacher, S. (2008) B56beta, a regulatory subunit of  protein phosphatase 2A, interacts with CALEB/NGC and inhibits CALEB/NGC-mediated  dendritic branching. 
  FASEB  Journal. 22, 2521-2533
• Mika, A., Buck, F.,and L¸thje, S. (2008) Membrane-bound class III peroxidases: identification,  biochemical properties and sequence analysis of isoenzymes purified from maize  (Zea mays  L.) roots.  Journal  of Proteomics. 71, 412-424
• Georgieva, D., K ardas, A., Buck, F., Perbandt, M. and Betzel C. (2008) Isolation, crystallization and preliminary X-ray  diffraction analysis of L-amino-acid oxidase from Vipera ammodytes ammodytes  venom.  Acta Crystallographica. Section F  64, 918-921

2007

• Kleene, R., Loers, G., Frobert, Y., Buck, F. and Schachner, M. (2007). Prion protein regulates glutamate-dependent lactate transport in astrocytes.  J. Neurosci. 27, 12331-12340
• Christenn, M., Kindler, S., Schulz, S., Buck, F., Richter, D. and Kreienkamp, H.-J. (2007). Interaction of brain somatostatin receptors with the PDZ domains of PSD-95. 
  FEBS-Lett. 581, 5173-5177
• Bretting, H., Buck, F., Jacobs, G., Meinke, S. Scheppokat, A.M. and Thiem, J. (2007). Tandem exploitation of Helix pomatia glycotransferases: facile synthesis of H-antigen-bearing oligosaccharides.  Chemistry 13, 7144-7152.

2006

• Heidebrecht, H.-J., Claviez, A., Kruse, M.L., Pollmann, M., Buck, F., Harder, S., Tiemann, M., Dörffel, W. and Parwaresch, R. (2006).  Characterization and Expression of CT45 in Hodgkins Lymphoma. Clin Cancer Res 12, 4804-4811
• Pollmann, M., Parwaresch, R., Adam-Klages, S., Kruse, M.-L., Buck, F. und Heidebrecht,
  H.-J. (2006)  Human EML4, a novel member of the EMAP family, is essential for microtubule formation.  Exp. Cell Res. 312, 3241-3251

2005

• Jüzsi, M., Richter, H., Lüschmann, I., Skerka, C., Buck, F., Beisiegel, U., Erdei, A. and Zipfel, P.F. (2005)  FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene.  Eur. J. Hum. Genetics 13, 321-329
• Rhode, H., Burdelski, C., Bartsch, K., Hussain, M., Buck, F., Horstkotte, M.A., Knobloch, J. K.-M., Heilmann, H., Herrmann, M. and Mack, D. (2005)  Induction of Stapylococcus epidermis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol. Microbiol. 55, 1883-1895
• Francke, F., Buck, F. and Bächner, D. (2005)  MYND domain specific interaction of the melatonin-concentrating hormone receptor 1 interaqcting zinc-finger protein with a# and b-tubulin. BBRC 3344, 1292-1298

2004

• Soltau, M., Berhörster, K., Kindler, S., Buck, F., Richter, D. and Kreienkamp, H.-J. (2004)  Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95.
  J. Neurochem. 90, 659-665
• Timmermann, M., Buck, F., Sorg, C. and Högger, P. (2004)  Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type A.  Immunology and Cell Biology 82, 479-487
• Brendel, C., Rehbein, M., Kreienkamp, H.-J., Buck, F., Richter, D. and Kindler, S. (2004)  Characterization of Staufen 1 ribinucleoprotein complexes.  Biochem. J. 384, 239-246

2003

• Heidebrecht, H.-J., Adam-Klages, S., Szczepanowski, M., Pollmann, M., Buck, F., Endl, E., Kruse, M.-L., Rudolph, P. and Parwaresch, R. (2003)  repp86: A human protein associated in the progression of mitosis. Mol. Cancer Res. 1, 271-279
• Obermeyer, N., Janson, N., Bergmann, J., Buck, F., and Ito, W. (2003)  Proteom analysis of migrating versus nonmigrating rat heart endothelial cells reveals distinct expression patters. Endothelium 10, 167-178

2002

• Windhorst, S., Frank, E., Georgieva, D.N., Genov, N., Buck, F., Borowski, P. and Weber, W. (2002).  The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia.. Characterization of the protein and molecular cloning of the gene. 
  J. Biol. Chem. 277, 11042-11049
• Rehbein, M., Wege, K., Buck, F., Schweizer, M., Richter, D. and Kindler, S. (2002). Molecular characterization of MARTA1, a protein interacting with the dendritic targeting element of MAP2 mRNAs.  J. Neurochem. 82, 1039-1046
• Kreienkamp, H.-J., Larusson, H.J., Witte, I., Roeder, T., Birg¸l, N., H^nck, H.-H, Harder, S., Ellinghausen, G., Buck, F. and Richter, D. (2002).  Functional annotation of two orphan G-coupled receptors, Drostar1 and-2, from Drosophila melanogaster and their ligands by reverse pharmacology.  J.Biol.Chem. 277, 39937-39943

2001

• Harder, S., Lu, X., Buck, F., Gershengorn, M.C. and Bruhn, T.O. (2001).  Regulator of G protein signaling suppresses basal and thyrotropin-releasing hormone stimulated signaling by two mouse TRH-receptors, TRH-R1 and TRH-R2.  Endocrinology 142, 1188-1194
• Mohr, E., Prakash, N., Vieluf, K., Fuhrmann, C., Buck, F. and Richtert, D. (2001). Vasopressin mRNA localisation in nerve cells: Characterization of cis-acting elements and trans-acting factors.  Proc. Natl. Acad. Sci. USA 98, 7072-7079
• Heidebrecht, H.-J., Buck, F., Endl, F., Kruse, M.-L., Adam-Klages, S., Andersen, K., Frahm, S.O., Schulte, C., Wacker, H.H. and Parwaresch, R. (2001).  Ki-Mcm6: Comparison of the distribution profile of Mcm6 and the Ki-67 antigen.  Laboratory Investigation 81, 1163-1165
• Harder, S., Dammann, O., Buck, F., Zwiers, H., Lederis, K., Richter, D. and Bruhn, T.O. (2001).  Cloning of two thyrotropin-releasing hormone receptor subtypes from a lower vertebrate (Catostomus commersoni): functional expression, gene structure and evolution.  Gen. Comp. Endocrinology 124, 236-245
• Böckers, T.M., Mameza, M.G., Kreutz, M.R., Bockmann, J., Weise, C., Buck, F., Richter, D., Gundelfinger, E.D. and Kreienkamp, H.J. (2001).  Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytosceletal protein alpha-fodrin.  J. Biol. Chem. 276, 40104-40112

2000

• Heidebrecht, H.J., Buck, F., Pollmann, M., Siebert, R. and Parwaresch, R. (2000). Cloning and localisation of C2orf2ropp120, a previously unknown WD repeat protein.  Genomics 68, 348-350
• Jürgensen, K., Buck, F., Lange, S., Kleine, M. and Grundler, F.M.W. (2000). A Beta vulgaris cDNA coding for a putative cytoplasmatic malate dehydrogenase (accession No. AJ251083). Plant Physiol. 122, 619
• Lellek, H., Kirsten, R., Diehl. I., Apostel, F., Buck, F., and Greeve,  J. (2000). Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing
  enzyme-complex.  J. Biol. Chem. 275, 19848-19856
• Reinard, T., Janke, V., Willard, J. Buck, F., Jacobsen, H. und Vockley, J. (2000). Cloning of a gene for an acyl-CoA dehydrogenase from Pisum sativum L. and purification and characterization of its product as an isovaleryl-CoA dehydrogenase.
  J. Biol. Chem. 275, 33738-33743
• Buck, F., Wang, W., Harder, S., Brathwaite, C., Bruhn, T.O. and Gershengorn, M.C. (2000).  Juxtamembrane regions in the third intracellular loop of the thyrotropin-releasing hormone receptor type 1 are important for coupling to Gq. Endocrinology 141, 3717-3722.

1999

• Hilz, H., Noldus, J., Hammerer, P., Buck, F., L¸ck, M. und Huland, H. (1999). Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors.   Eur. Urol. 36, 286-292
• Marg, A., Sirim, P., Spaltmann, F., Plagge, A., Kauselmann, G., Buck, F., Rathjen, F.G. and Br¸mmendorf, T. (1999). Neurotractin, a novel neurite outgrowth-promoting Ig-like protein that interacts with CEPU-1 and LAMP.  J. Cell Biol. 145, 865-876
• Bächner, D., Kreienkamp, H.-J., Weise, C., Buck, F. und Richter, D. (1999). Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-1).  FEBS Lett. 457, 522-524

1998

• Högger, P., Dreier, J., Droste, A., Buck, F. and Sorg, C. (1998). Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cystein-rich family (CD 163). J. Immunol. 161, 1883-1890.
• Wang, X., Buck, F. and Havsteen, B. (1998) Elucidation of a new biological function of an old protein: unique structure of the cobra serum albumin controls its specific toxin binding activity. Int. J. Biochem. Cell Biol. 30, 225-233.
• Buck, F., Schulze, C., Breloer, M. Strupat, K. and Bretting, H. (1998). Amino acid sequence of the D-galactose binding lectin II from the sponge Axinella polypoides (Schmidt) and identification of the carbohydrate binding site in lectin II and related lectin I.  Comp. Biochem. Physiol. 121, 153-160